Rezolute Newsroom

Maxim Group Maintains Rezolute(RZLT.US) With Buy Rating, Announces Target Price $12

Moomoo NewsNov 9 10:31 ET

H.C. Wainwright Maintains Rezolute(RZLT.US) With Buy Rating, Maintains Target Price $14

Moomoo NewsNov 8 11:31 ET

Rezolute Analyst Ratings

BenzingaNov 8 11:30 ET

Wedbush Maintains Rezolute(RZLT.US) With Buy Rating, Maintains Target Price $12

Moomoo NewsNov 8 07:35 ET

JMP Securities Maintains Rezolute(RZLT.US) With Buy Rating, Raises Target Price to $8

Moomoo NewsNov 8 01:31 ET

Rezolute's Promising Pipeline and Financial Stability Drive Buy Rating and Increased Price Target

TipRanksNov 8 00:51 ET

Wedbush Initiates Rezolute(RZLT.US) With Buy Rating, Announces Target Price $12

Moomoo NewsNov 5 18:31 ET

Rezolute Price Target Announced at $12.00/Share by Wedbush

Dow JonesNov 5 04:51 ET

Rezolute Analyst Ratings

BenzingaNov 5 04:41 ET

Rezolute Initiated With an Outperform at Wedbush

TipRanksNov 4 16:49 ET

Rezolute Initiated With an Outperform at Wedbush

TipRanksNov 4 16:49 ET

CCORF Maintains Rezolute(RZLT.US) With Buy Rating, Maintains Target Price $9

Moomoo NewsOct 3 08:34 ET

H.C. Wainwright Maintains Rezolute(RZLT.US) With Buy Rating, Maintains Target Price $14

Moomoo NewsSep 27 06:31 ET

Rezolute Analyst Ratings

BenzingaSep 20 10:30 ET

BTIG Maintains Rezolute(RZLT.US) With Buy Rating, Maintains Target Price $15

Moomoo NewsSep 20 06:31 ET

Analysts' Opinions Are Mixed on These Healthcare Stocks: Rezolute (RZLT) and Gryphon Digital Mining (GRYP)

TipRanksSep 20 06:22 ET

JMP Securities Maintains Rezolute(RZLT.US) With Buy Rating, Maintains Target Price $7

Moomoo NewsSep 20 00:31 ET

Buy Rating Affirmed for Rezolute Amidst Progressive Clinical Trials and Strong Financial Position

TipRanksSep 20 00:25 ET

Maxim Group Maintains Rezolute(RZLT.US) With Buy Rating

Moomoo NewsSep 10 11:31 ET

Rezolute's Drug Pipeline Progress and FDA Hold Lift Propel Buy Rating and Increased Price Target

TipRanksSep 10 10:37 ET